TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20562469

Group type: EXPERIMENTAL
Intervention: PPN stimulation at therapeutic frequencies (20-35 Hz)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Chronic PPN stimulation
Number of subjects: 11

Group type: COMPARATOR
Intervention: PPN stimulation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Baseline performance
Number of subjects: 11
Study: 18192132

Group type: EXPERIMENTAL
Intervention: daily‐dose blister packaging (Pill Calendar)
Number of subjects: 85

Group type: COMPARATOR
Intervention: traditional bottles of loose tablets
Number of subjects: 85
Study: 16169353

Group type: EXPERIMENTAL
Intervention: COPD
Number of subjects: 10994
Study: 14728840

Group type: EXPERIMENTAL
Intervention: Intervening measures (six measures used)
Number of subjects: 1597

Group type: COMPARATOR
Intervention: Control group (no intervening measures)
Number of subjects: 1597
Study: 10229296

Group type: EXPERIMENTAL
Intervention: Epalrestat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SNK-860
Number of subjects: 0
Study: 8696904

Group type: EXPERIMENTAL
Intervention: Intravenous heparin
Number of subjects: 284

Group type: COMPARATOR
Intervention: No heparin
Number of subjects: 284
Study: 2607269

Group type: EXPERIMENTAL
Intervention: Hand instrumentation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ultrasonic instrumentation with the Cavi‐Endo unit
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ultrasonic instrumentation with the Enac unit
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sonic instrumentation with the Medidenta unit
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sonic instrumentation with the Endostar 5 unit
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (tap water)
Number of subjects: 50
Study: 776090

Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate cream
Number of subjects: 180

Group type: COMPARATOR
Intervention: Fluocinolone acetonide cream
Number of subjects: 180
Study: 30927579

Group type: EXPERIMENTAL
Intervention: Brief mindfulness-based stress management program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Psychoeducation using a leaflet
Number of subjects: 80
Study: 28526481

Group type: EXPERIMENTAL
Intervention: Telephone support call (2‐10 minutes) 3 days before or 3 days after receiving an invitation letter to physiotherapy sessions
Number of subjects: 130

Group type: COMPARATOR
Intervention: No telephone support call
Number of subjects: 130
Study: 26681630

Group type: EXPERIMENTAL
Intervention: Aerobic training (AG)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Combined training (CG)
Number of subjects: 33
Study: 22920242

Group type: EXPERIMENTAL
Intervention: Valgus knee brace
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Lateral wedged insole
Number of subjects: 28
Study: 21481265

Group type: EXPERIMENTAL
Intervention: Workplace physical activity intervention (3 month tool-kit of activities targeting components of the Theory of Planned Behavior)
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1260
Study: 18207228

Group type: EXPERIMENTAL
Intervention: ALED-I intervention (16-week program)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Delayed intent-to-treat control condition
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: ALED-I intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 32
Study: 21975580

Group type: EXPERIMENTAL
Intervention: THC (500 μg/kg body weight)
Number of subjects: 24
Study: 16019368

Group type: EXPERIMENTAL
Intervention: 10 mg testosterone gel
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 20 mg testosterone gel
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 30 mg testosterone gel
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Baseline testosterone levels
Number of subjects: 15
Study: 12090970

Group type: EXPERIMENTAL
Intervention: Community Youth Service (CYS)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Curriculum-only condition (Control)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: 1 year of CYS
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: 2 years of CYS
Number of subjects: 195
Study: 10518865

Group type: EXPERIMENTAL
Intervention: Arm & Hammer Dental Care Extra Whitening
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Arm & Hammer Dental Care
Number of subjects: 115

Group type: COMPARATOR
Intervention: Crest
Number of subjects: 115
Study: 8027217

Group type: EXPERIMENTAL
Intervention: Alprazolam (APZ) 2 mg orally
Number of subjects: 8

Group type: COMPARATOR
Intervention: AVP (0.0143 IU/kg BW, iv)
Number of subjects: 8
Study: 2692094

Group type: EXPERIMENTAL
Intervention: Ofloxacin (200 mg tid for 10 days)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Amoxycillin (1 g tid for 10 days)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 41

Group type: COMPARATOR
Intervention: Amoxycillin
Number of subjects: 41
Study: 818040

Group type: EXPERIMENTAL
Intervention: Rheumapax
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 31522785

Group type: EXPERIMENTAL
Intervention: l-arginine infusion (1.2 μmol kg-1 min-1)
Number of subjects: 18
Study: 29666372

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 16
Study: 26473986

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 8 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 0
Study: 24118306

Group type: EXPERIMENTAL
Intervention: Total atrial conduction time (TACT) assessed via tissue Doppler imaging (PA‐TDI interval) measured 6 hours after successful direct‐current electrical cardioversion (CV)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (patients who maintained sinus rhythm)
Number of subjects: 54
Study: 22211402

Group type: EXPERIMENTAL
Intervention: IPV ablation (IPVA)
Number of subjects: 69

Group type: COMPARATOR
Intervention: GSV ablation (GSVA)
Number of subjects: 69
Study: 21103799

Group type: EXPERIMENTAL
Intervention: Active theater program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Physiotherapy (control group)
Number of subjects: 20
Study: 18502545

Group type: EXPERIMENTAL
Intervention: PCV7 with DTaP-IPV-HBV-Hib
Number of subjects: 266

Group type: COMPARATOR
Intervention: DTaP-IPV-HBV-Hib
Number of subjects: 266
Study: 16006888

Group type: EXPERIMENTAL
Intervention: Vaccine therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nilutamide (antiandrogen therapy)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combined therapy (vaccine + nilutamide)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combined therapy (vaccine + nilutamide) after vaccine arm progression
Number of subjects: 42
Study: 12094191

Group type: EXPERIMENTAL
Intervention: Heparin dosing of approximately 14 U/kg/h or an aPTT of approximately 70 seconds
Number of subjects: 5335

Group type: EXPERIMENTAL
Intervention: Heparin therapy
Number of subjects: 5335

Group type: EXPERIMENTAL
Intervention: Heparin dosing
Number of subjects: 5335

Group type: EXPERIMENTAL
Intervention: Heparin resistance with high dosages and low aPTT values
Number of subjects: 5335
Study: 10521156

Group type: EXPERIMENTAL
Intervention: Interventions designed to influence age at first intercourse and improve educational performance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Teenage mothers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Areas of the country with higher rates of teenage motherhood
Number of subjects: 0
Study: 7670342

Group type: EXPERIMENTAL
Intervention: Millimetric electromagnetic radiation (MER) therapy using wavelengths of 6.4 and 7.1 mm on a YAVOR device for 10 sessions
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (specific drugs without MER therapy)
Number of subjects: 54
Study: 2111754

Group type: EXPERIMENTAL
Intervention: Surfactant
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 7004051

Group type: EXPERIMENTAL
Intervention: Oral PGE2 (0.5 mg initially, followed by 1.0 mg every hour for up to 24 hours)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intravenous oxytocin (starting at 5 mIU/min, increasing to 20 mIU/min)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Oral PGE2
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both treatments (PGE2 and oxytocin)
Number of subjects: 200
Study: 31781890

Group type: EXPERIMENTAL
Intervention: Indwelling cannulas drain of seroma (Group A)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Needle aspiration of seroma (Group B)
Number of subjects: 86
Study: 31204104

Group type: EXPERIMENTAL
Intervention: Helmetless tackling/blocking drills (WoH)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Upper-level WoH participants
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (normal training)
Number of subjects: 115
Study: 28478996

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics (risperidone, olanzapine, quetiapine)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Antipsychotic treatment
Number of subjects: 9

Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 9
Study: 25526906

Group type: EXPERIMENTAL
Intervention: Daidzein (500 mg/kg concentrate)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 23648344

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (0.8 mg×kg(‐1)×d(‐1)) therapy
Number of subjects: 28
Study: 21819161

Group type: EXPERIMENTAL
Intervention: Pantoprazole-Mg 40 mg once daily for 8 weeks
Number of subjects: 636

Group type: COMPARATOR
Intervention: Pantoprazole-Na 40 mg once daily for 8 weeks
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Pantoprazole-Mg 40 mg once daily for 4 weeks
Number of subjects: 636

Group type: COMPARATOR
Intervention: Pantoprazole-Na 40 mg once daily for 4 weeks
Number of subjects: 636
Study: 19135834

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Newspaper advertising
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Mailed recruitment letters to patients with PAD
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Radio advertising
Number of subjects: 746

Group type: COMPARATOR
Intervention: Television advertising
Number of subjects: 746

Group type: COMPARATOR
Intervention: Life Line Screening
Number of subjects: 746

Group type: COMPARATOR
Intervention: Mailed postcards to older community dwelling men and women
Number of subjects: 746
Study: 17876969

Group type: EXPERIMENTAL
Intervention: Youth self-efficacy (SEPA) measures for physical activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proxy efficacy (PEPA) measures for physical activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in SEPA scales
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial levels of PEPA-Parents and SEPA scales
Number of subjects: 0
Study: 14550591

Group type: EXPERIMENTAL
Intervention: Chlorhexidine vaginal irrigation
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 10724056

Group type: EXPERIMENTAL
Intervention: Biweekly directly observed preventive therapy with a $5 monetary incentive
Number of subjects: 118

Group type: COMPARATOR
Intervention: Biweekly directly observed preventive therapy using a peer health adviser
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care at the tuberculosis clinic
Number of subjects: 118
Study: 8956924

Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combination of VGB and CBZ
Number of subjects: 51
Study: 1551748

Group type: EXPERIMENTAL
Intervention: 4.5 mg slow‐release co‐dergocrine mesylate administered once daily for 6 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4.5 mg slow‐release co‐dergocrine mesylate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3873389

Group type: EXPERIMENTAL
Intervention: Oral, nonabsorbable antibiotics (gentamicin + vancomycin + nystatin or neomycin + colistin + nystatin)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no oral, nonabsorbable antibiotics)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Oral, nonabsorbable antibiotics
Number of subjects: 140
Study: 31618127

Group type: EXPERIMENTAL
Intervention: GC4419 90 mg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: GC4419 30 mg
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 29300737

Group type: EXPERIMENTAL
Intervention: HemoCue® wicking method
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: HemoCue® gravity method
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Pronto® DCI‐mini™
Number of subjects: 132
Study: 27871280

Group type: EXPERIMENTAL
Intervention: Stereotactic radiation therapy (n=55)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard radiotherapy (n=55)
Number of subjects: 110
Study: 24772445

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 107
Study: 23165580

Group type: EXPERIMENTAL
Intervention: Synbiotic dairy product containing Bifidobacterium BB12, Lactobacillus casei CRL 431 and fiber
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control yoghurt
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Synbiotic yoghurt
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Synbiotic dairy product
Number of subjects: 102
Study: 20159245

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Nedocromil
Number of subjects: 909

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: All treatments (Budesonide, Nedocromil, Placebo)
Number of subjects: 909
Study: 18612130

Group type: EXPERIMENTAL
Intervention: Iron reduction (phlebotomy)
Number of subjects: 1277

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1277
Study: 16080282

Group type: EXPERIMENTAL
Intervention: Fosfomycin trometamol (FT) 3 g every 10 days for 6 months
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo (PL) every 10 days for 6 months
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Fosfomycin trometamol (FT)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 317
Study: 11821721

Group type: EXPERIMENTAL
Intervention: Active nitrendipine
Number of subjects: 4695

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 4695

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 4695

Group type: COMPARATOR
Intervention: Placebo for nitrendipine
Number of subjects: 4695

Group type: COMPARATOR
Intervention: Placebo for enalapril
Number of subjects: 4695

Group type: COMPARATOR
Intervention: Placebo for hydrochlorothiazide
Number of subjects: 4695
Study: 9808110

Group type: EXPERIMENTAL
Intervention: Gabapentin group (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n=15)
Number of subjects: 30
Study: 7702152

Group type: EXPERIMENTAL
Intervention: Pre-operative oral fluids (water)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Normal fasting regimen
Number of subjects: 95
Study: 2694861

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 micrograms/kg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 46
Study: 363484

Group type: EXPERIMENTAL
Intervention: Celestone Chronodose (subacromial injection)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Celestone Chronodose (gluteal injection)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 31779925

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure reduction with diuretics
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard blood pressure reduction with diuretics
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Diuretic use
Number of subjects: 9361
Study: 29872803

Group type: EXPERIMENTAL
Intervention: 3 g high MW (HMW) barley β-glucan
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 5 g low MW (LMW) barley β-glucan
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3 g low MW (LMW) barley β-glucan
Number of subjects: 30
Study: 26439789

Group type: EXPERIMENTAL
Intervention: Breakdown (BD) training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Heavy-load breakdown training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Traditional resistance training
Number of subjects: 36

Group type: COMPARATOR
Intervention: All groups (BD, heavy-load breakdown, traditional)
Number of subjects: 36
Study: 24483133

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic surgery (SPLS)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Conventional laparoscopic surgery (CLS)
Number of subjects: 230
Study: 23250715

Group type: EXPERIMENTAL
Intervention: Small head (28-32 mm) metal on polyethylene (MoP) articulation
Number of subjects: 49

Group type: COMPARATOR
Intervention: Large head (44-54 mm) metal on metal (MoM) articulation
Number of subjects: 49
Study: 21130977

Group type: COMPARATOR
Intervention: losartan 100 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: isosorbide mononitrate (ISMN) 60 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: losartan 100 mg + ISMN 15 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: losartan 100 mg + ISMN 60 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13
Study: 17984166

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg per day
Number of subjects: 5011

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5011
Study: 16121346

Group type: EXPERIMENTAL
Intervention: EGD plus EUS (EGD/EUS group)
Number of subjects: 105

Group type: COMPARATOR
Intervention: EGD only (EGD group)
Number of subjects: 105
Study: 11581232

Group type: EXPERIMENTAL
Intervention: Cefepime 2 g iv bd
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cefotaxime 2 g iv tds
Number of subjects: 160
Study: 9699698

Group type: EXPERIMENTAL
Intervention: Skills training
Number of subjects: 80

Group type: COMPARATOR
Intervention: Psychosocial occupational therapy
Number of subjects: 80
Study: 8021762

Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 2691539

Group type: EXPERIMENTAL
Intervention: HPL bitewing device
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional freehand method
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rinn XCP instrument
Number of subjects: 30
Study: 7931739

Group type: EXPERIMENTAL
Intervention: Referral to a community physician, monthly 10‐minute work‐site counseling sessions including blood pressure readings, and personalized mailings
Number of subjects: 159

Group type: COMPARATOR
Intervention: Physician referral only
Number of subjects: 159
Study: 626273

Group type: EXPERIMENTAL
Intervention: Tinidazole (2 g single dose)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (four tablets)
Number of subjects: 55
Study: 31532482

Group type: EXPERIMENTAL
Intervention: Online patient portal for CRC screening decision support program
Number of subjects: 0
Study: 28732800

Group type: EXPERIMENTAL
Intervention: Trichloroacetic acid (TCA) 25%
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Trichloroacetic acid (TCA) 40%
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Phenol/croton oil
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 9
Study: 26559740

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) using InGaAlP (660 nm-100 mW-4J/cm2) laser diode.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (no treatment).
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT).
Number of subjects: 94
Study: 25226108

Group type: EXPERIMENTAL
Intervention: Nutrition risk assessment using the Australian Nutrition Screening Initiative (ANSI)
Number of subjects: 3893

Group type: EXPERIMENTAL
Intervention: Quality of life assessment using WHOQOL-BREF
Number of subjects: 3893

Group type: EXPERIMENTAL
Intervention: Physical function assessment using the Nottingham Extended Activities of Daily Living
Number of subjects: 3893

Group type: EXPERIMENTAL
Intervention: Depressive symptoms assessment using the 15 item Geriatric Depression Scale
Number of subjects: 3893
Study: 22888655

Group type: EXPERIMENTAL
Intervention: Irradiation by 2 fractions of 6.5 Gy
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Irradiation by 3 fractions of 6.5 Gy
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Irradiation by 4 fractions of 6.5 Gy
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Multiple small fraction irradiation
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Irradiation for breast cancer patients
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Irradiation for prostate cancer patients
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Irradiation for lung cancer patients
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Irradiation for renal cancer patients
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Overall pain recurrence in irradiated area
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Recommended irradiation for breast and prostate cancer patients
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Recommended irradiation for lung and renal cancer patients
Number of subjects: 333
Study: 19470154

Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte transplantation (AC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Subchondral drilling (SD)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Serum WF6 levels
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Serum HA levels
Number of subjects: 10
Study: 17894335

Group type: EXPERIMENTAL
Intervention: Continuous infusion of apomorphine hydrochloride for 5 days
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo infusion for 5 days
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Continuous infusion of apomorphine hydrochloride
Number of subjects: 5

Group type: COMPARATOR
Intervention: Continuous infusion of apomorphine hydrochloride and placebo
Number of subjects: 5
Study: 15041714

Group type: EXPERIMENTAL
Intervention: BMS‐275291 (1200 mg/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72